Leerink cuts Dentsply Sirona target from USD 14 to USD 10 for Dentsply Sirona stock

Published on 10/20/2026 at 13:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue fell 4.10 percent to USD 898.0 million. Dentsply Sirona stock costs EUR 7.52 on October 20, 2026 at Lang & Schwarz.

Three dated signals

Leerink Partners cut its Dentsply Sirona target from USD 14.00 to USD 10.00 on October 14, 2026.
Second-quarter 2026 revenue fell 4.10 percent year over year to USD 898.0 million.
Dentsply Sirona stock traded at EUR 7.52 at 1:13 p.m. CEST at Lang & Schwarz on October 20, 2026.

XRAY, US24906P1093, Illustration mit AI erstellt.

Dentsply Sirona (US24906P1093) faces a lower analyst valuation after Leerink Partners cut its price target from USD 14.00 to USD 10.00 on October 14, 2026, according to TradingView. Dentsply Sirona stock was trading at EUR 7.52 at Lang & Schwarz on October 20, 2026 at 1:13 p.m. CEST.

Target cuts sharpen the valuation debate

The Leerink revision follows a broader reassessment of the dental-equipment maker's turnaround prospects. Markets Insider reported on October 9, 2026 that Piper Sandler lowered its target from USD 14.00 to USD 12.00 while keeping a Neutral rating.

That caution sits alongside a mixed second quarter. Dentsply Sirona generated USD 898.0 million of revenue in the second quarter of 2026, down 4.10 percent from the same quarter of 2025, while net income reached USD 37.0 million and diluted earnings per share were USD 0.18. The standardized financial statements identify operating margin at 9.00 percent for the quarter.

What do the operating figures mean?

The revenue decline is the key counterweight to the return to profitability. In the first quarter of 2026, revenue was USD 880.0 million and net income was a USD 10.0 million loss, so second-quarter revenue increased by USD 18.0 million and net income improved by USD 47.0 million sequentially.

Three dated milestones for XRAY

Dentsply Sirona reported second-quarter 2026 results on August 6, 2026, with revenue of USD 898.0 million. On October 6, 2026, the company announced that Midwest Dental Equipment and Supply would begin distributing its technology portfolio in the United States on November 1, 2026, according to Yahoo Finance. Leerink then cut its target to USD 10.00 on October 14, 2026.

Which dates come next?

The Midwest Dental technology expansion is scheduled to take effect on November 1, 2026, while Dentsply Sirona is scheduled to report September 2026 results on November 5, 2026, according to MetaCap.

Stock context after the target cut

On Nasdaq, XRAY was last at USD 8.42 on October 19, 2026 at 4:00 p.m. ET. The Nasdaq-listed stock had a 52-week range of USD 8.32 to USD 14.76 on the cited market snapshot, leaving the operating recovery and dealer expansion as the next measurable tests.

Dentsply Sirona was trading at EUR 7.52 at Lang & Schwarz on October 20, 2026 at 1:13 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Dentsply Sirona stock.